Diagnosis and treatment of low‐renin hypertension

P Mulatero, A Verhovez, F Morello… - Clinical …, 2007 - Wiley Online Library
Plasma renin levels can be used to classify hypertension. A significant proportion of
hypertensive individuals display a low‐renin profile and thus low‐renin hypertension (LRH) …

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single …

H Itoh, S Ito, H Rakugi, Y Okuda, S Nishioka - Hypertension Research, 2019 - nature.com
The stimulation of mineralocorticoid receptors is linked to the development of hypertension
and cardiovascular or renal damage in patients with diabetes, and the blockade of these …

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone

H Rakugi, S Yamakawa, K Sugimoto - Hypertension Research, 2021 - nature.com
The nonsteroidal mineralocorticoid receptor (MR) blocker esaxerenone has demonstrated
good antihypertensive activity in a variety of patients, including those with uncomplicated …

Physiological phenotyping for personalized therapy of uncontrolled hypertension in Africa

A Akintunde, J Nondi, K Gogo… - American Journal of …, 2017 - academic.oup.com
Abstract OBJECTIVES African and African American hypertensives tend to retain salt and
water, with lower levels of plasma renin and more resistant hypertension. We tested the …

Chlorthalidone for resistant hypertension in advanced chronic kidney disease

R Agarwal, AD Sinha, W Tu - Circulation, 2022 - Am Heart Assoc
Resistant hypertension increases the risk for cardiovascular events and end-stage kidney
disease. 1 Few therapies exist for people with chronic kidney disease (CKD). In a double …

Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment

MC Acelajado, DA Calhoun - Cardiology clinics, 2010 - cardiology.theclinics.com
Hypertension (defined as BP> 140/90 mm Hg) is a global burden, affecting as many as 1
billion individuals worldwide and causing 7.5 million deaths (12.8% of all deaths) per year. 1 …

The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio

SJ Hood, KP Taylor, MJ Ashby, MJ Brown - Circulation, 2007 - Am Heart Assoc
Background—There is continuing variation in diagnosis and estimated prevalence of
primary hyperaldosteronism. The higher estimates encourage search for adrenal adenomas …

Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study

E Pimenta, RD Gordon, AH Ahmed… - The Journal of …, 2011 - academic.oup.com
Context: Animal studies have demonstrated that dietary sodium intake is a major influence in
the pathogenesis of aldosterone-induced effects in the heart such as left ventricular (LV) …

[PDF][PDF] Renal denervation to treat resistant hypertension: guarded optimism

G Thomas, MH Shishehbor, EL Bravo, JV Nally - Cleve Clin J Med, 2012 - cdn.mdedge.com
Renal sympathetic denervation has shown promise in treating hypertension resistant to drug
therapy. This procedure lowers blood pressure via targeted attenuation of renal sympathetic …

Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin–angiotensin–aldosterone system

B Alvarez-Alvarez, M Abad-Cardiel… - Journal of …, 2010 - journals.lww.com
Background Currently there is no consensus regarding which add-on therapy to use in
resistant hypertension. This study was designed to compare two treatment options …